These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 6281229)

  • 1. Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():101-6. PubMed ID: 6281229
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
    Baker CN; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Miller MA; LeFrock JL; Vercler MJ
    Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
    Simard P; Bergeron MG
    J Antimicrob Chemother; 1982 Nov; 10(5):397-402. PubMed ID: 6294044
    [No Abstract]   [Full Text] [Related]  

  • 5. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Traub WH
    Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
    Pulverer G; Peters G
    Med Welt; 1982 Apr; 33(17):642-4. PubMed ID: 6285119
    [No Abstract]   [Full Text] [Related]  

  • 7. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
    Magnussen CR; Sammartino MT; Ernest KD
    Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.
    Moody JA; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1984 Aug; 26(2):256-9. PubMed ID: 6435516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
    Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
    Lang SD; Edwards DJ; Durack DT
    Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
    Calderwood SB; Tung CC; Jackson E
    J Clin Microbiol; 1984 May; 19(5):707-9. PubMed ID: 6330168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
    Greenfield RA; Kurzynski TA; Craig WA
    Antimicrob Agents Chemother; 1982 May; 21(5):846-7. PubMed ID: 6285817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
    Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ
    Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vitro activity of mezlocillin against community hospital isolates in comparison to other penicillins and cephalosporins.
    Parry MF; Folta D
    J Antimicrob Chemother; 1983 May; 11 Suppl C():97-102. PubMed ID: 6619043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
    Mintz L; Drew WL
    Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
    Monteil H; Peladan F; Zinsius M
    Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new cephalosporins and penicillins.
    Weinstein AJ
    Compr Ther; 1982 Feb; 8(2):26-31. PubMed ID: 6279354
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences among moxalactam, cefoperazone, and cefotaxime in activity against multiple-antibiotic-resistant gram-negative bacteria.
    Preston DA
    Rev Infect Dis; 1982; 4 Suppl():S516-21. PubMed ID: 6296965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.